Kessler Investment Group LLC Purchases Shares of 16,868 iShares Biotechnology ETF $IBB

Kessler Investment Group LLC purchased a new stake in shares of iShares Biotechnology ETF (NASDAQ:IBB) during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund purchased 16,868 shares of the financial services provider’s stock, valued at approximately $2,847,000. iShares Biotechnology ETF comprises approximately 1.2% of Kessler Investment Group LLC’s holdings, making the stock its 25th largest holding.

Several other hedge funds and other institutional investors have also made changes to their positions in the business. Darwin Wealth Management LLC acquired a new stake in iShares Biotechnology ETF in the 2nd quarter valued at approximately $25,000. Cornerstone Planning Group LLC acquired a new position in iShares Biotechnology ETF during the 4th quarter worth $35,000. Strategic Wealth Advisors LLC acquired a new position in iShares Biotechnology ETF during the 4th quarter worth $35,000. Ashton Thomas Securities LLC bought a new position in shares of iShares Biotechnology ETF in the third quarter worth $36,000. Finally, Parkside Financial Bank & Trust grew its stake in shares of iShares Biotechnology ETF by 48.6% in the third quarter. Parkside Financial Bank & Trust now owns 266 shares of the financial services provider’s stock worth $38,000 after purchasing an additional 87 shares in the last quarter. 62.45% of the stock is currently owned by institutional investors and hedge funds.

iShares Biotechnology ETF Price Performance

Shares of IBB opened at $169.94 on Friday. iShares Biotechnology ETF has a one year low of $116.49 and a one year high of $179.64. The stock’s fifty day moving average is $169.61 and its 200-day moving average is $169.03.

iShares Biotechnology ETF Cuts Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, March 20th. Investors of record on Tuesday, March 17th were given a $0.1218 dividend. This represents a $0.49 dividend on an annualized basis and a yield of 0.3%. The ex-dividend date was Tuesday, March 17th.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.